2977 related articles for article (PubMed ID: 25141367)
1. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
3. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
5. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
6. [The effect of omega-3 fatty acids on risk factors for cardiovascular diseases].
Yam D; Bott-Kanner G; Genin I; Shinitzky M; Klainman E
Harefuah; 2001 Dec; 140(12):1156-8, 1230. PubMed ID: 11789299
[TBL] [Abstract][Full Text] [Related]
7. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
[TBL] [Abstract][Full Text] [Related]
8. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
10. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
Feuerstein JS; Bjerke WS
J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
[TBL] [Abstract][Full Text] [Related]
11. Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.
Becker DJ; French B; Morris PB; Silvent E; Gordon RY
Am Heart J; 2013 Jul; 166(1):187-96. PubMed ID: 23816039
[TBL] [Abstract][Full Text] [Related]
12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
13. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
Jacobson TA; Glickstein SB; Rowe JD; Soni PN
J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
[TBL] [Abstract][Full Text] [Related]
14. Elevation of low-density lipoprotein cholesterol concentration with over-the-counter fish oil supplementation.
Malinowski JM; Metka K
Ann Pharmacother; 2007 Jul; 41(7):1296-300. PubMed ID: 17609237
[TBL] [Abstract][Full Text] [Related]
15. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
16. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
20. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
